Artículos del autor

solaci

Femoropopliteal

Deep Vein Arterialization: Have We Conquered “Non-Revascularizable” Critical Limb Ischemia?

Deep vein Arterialization in patients with critical “non-revascularizable” limb ischemia.  We are familiar with the poor quality of...
solaci -
Institutional News

04/19 – SOLACI-LATAM Bif Webinar | Use of Drug Coated Balloons in Complex PCI

On Wednesday, April 19th, at 7 pm (Argentinian/Brazil time) we will be holding a new open event...
solaci -
Mitral valve

MitraScore: What Does the Final Result of Edge-to-Edge Treatment of Mitral Regurgitation Provide?

Edge-to-edge treatment has proven to be a safe and effective technique in follow-up, decreasing mortality and hospitalizations...
solaci -
Institutional News

04/12 – SOLACI@Medtronic Webinar: Lifetime Management Applied to Clinical Practice

Next Wednesday, April 12, at 8:00 p.m. (Argentina / Brazil time), we will hold a new open...
solaci -
Aorta

SAFE-AAA: Are the New Endologix Devices for Abdominal Aortic Aneurysm Safe? 3-Year Followup

New unibody endologix endografts for the endovascular repair of abdominal aortic aneurysm 3-4-year safety followup  At present, we have seen...
solaci -
Structural heart disease

Amyloidosis and TAVR: Does this Disease Have an Impact?

Amyloidosis is a systemic disease that affects different organs and impairs their function. Recent studies with magnetic resonance...
solaci -
Structural heart disease

When Is It Best to Fracture a Bioprosthesis in TAVR?

At present, surgical aortic valve replacement (SAVR) uses bioprostheses. However, when these fail, we are presented with...
solaci -
Other

Survival in Patients with Tricuspid Regurgitation According to Clinical and Echocardiographic Variables (Clusters)

Survival analysis of patients with tricuspid regurgitation grouped according to comorbidities and echocardiographic variables. For many years, the...
solaci -